Chewable tablets (EMA) [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2012-01-11 15:19 (5285 d 06:45 ago) – Posting: # 7900
Views: 9,246

Dear Jagdish!

❝ Dear HS,

   ^^ not interested in opinions of other members?


❝ can you tell me how montelukast should be administered during BE study for european submission with water after chewing or without water after chewing


See the GL, Appendix II, Orodispersible tablets and the last paragraph:

Other oral formulations such as […] chewable tablets may be handled in a similar way as for ODTs. Bioequivalence studies should be conducted according to the recommended use of the product.


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
404 visitors (0 registered, 404 guests [including 112 identified bots]).
Forum time: 23:05 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5